Clinical Trial Update: Efficacy of Erythropoietin to Prevent Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing Cardiac Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether erythropoietin can prevent acute kidney injury in patients with chronic kidney disease undergoing cardiac surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Kidney Injury

Drugs mentioned

• Erythropoietin (epoetin alfa) (epoetin alfa)

Snippet

Sponsor: Thammasat University | Conditions: Acute Renal Failure | Phase 3 | Status: UNKNOWN